Brezivaptan

Brezivaptan

Brezivaptan is a pharmaceutical compound that acts as a selective antagonist of the vasopressin V1A receptor. It is primarily investigated for its potential therapeutic applications in cardiovascular diseases and other conditions where vasopressin plays a significant role.

Pharmacology

Brezivaptan functions by inhibiting the action of vasopressin at the V1A receptor. Vasopressin, also known as antidiuretic hormone (ADH), is a peptide hormone that regulates the body's retention of water and vasoconstriction. The V1A receptor is one of the three main receptor subtypes for vasopressin, with the others being V1B and V2 receptors.

Mechanism of Action

Brezivaptan binds to the V1A receptor, preventing vasopressin from exerting its effects. This blockade results in vasodilation and a reduction in blood pressure, making it a potential treatment for conditions such as hypertension and heart failure. By selectively targeting the V1A receptor, Brezivaptan aims to minimize side effects associated with non-selective vasopressin receptor antagonists.

Clinical Applications

Brezivaptan is under investigation for several clinical applications, including:

• Hypertension: By blocking the V1A receptor, Brezivaptan may help lower blood pressure in patients with hypertension.
• Heart Failure: The vasodilatory effects of Brezivaptan can reduce the workload on the heart, potentially benefiting patients with heart failure.
• Other Conditions: Research is ongoing to explore the use of Brezivaptan in other conditions where vasopressin plays a role, such as certain types of kidney disease.

Research and Development

Brezivaptan is currently in various stages of clinical trials. The outcomes of these trials will determine its efficacy and safety profile, as well as its potential approval for clinical use.

Side Effects

As with any pharmacological agent, Brezivaptan may have side effects. Common side effects observed in clinical trials include:

• Hypotension (low blood pressure)
• Dizziness
• Headache

Further studies are needed to fully understand the side effect profile of Brezivaptan.

Also see

• Vasopressin
• Vasopressin receptor antagonist
• Hypertension
• Heart failure

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy